Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human α7 nicotinic acetylcholine receptor

Hugo R. Arias, Ruo Xu Gu, Dominik Feuerbach, Dong Qing Wei

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The interaction of the agonist JN403 with the human (h) α7 nicotinic acetylcholine receptor (AChR) was compared to that for the competitive antagonist methyllycaconitine (MLA). The receptor selectivity of JN403 was studied on the hα7, hα3β4, and hα4β2 AChRs. The results established that the cationic center and the hydrophobic group found in JN430 and MLA are important for the interaction with the AChRs. MLA preincubation inhibits JN403-induced Ca2+ influx in GH3-hα7 cells with a potency 160-fold higher than that when MLA is co-injected with JN403. The most probable explanation, based on our dynamics results, is that MLA (more specifically the 3-methyl-2,5-dioxopyrrole ring and the B-D rings) stabilizes the resting conformational state. The order of receptor specificity for JN403 is as follows: hα7 > hα3β4 (∼40-fold) > hα4β2 (∼500-fold). This specificity is based on a larger number of hydrogen bonds between the carbamate group (another pharmacophore) of JN403 and the hα7 sites, the electrostatic repulsion between the positively charged residues around the hα3β4 sites and the cationic center of JN403, fewer hydrogen bonds for the interaction of JN403 with the hα3β4 AChR, and an unfavorable van der Waals interaction between JN403 and the α4-β2 interface. The higher receptor specificity for JN403 could be important for the treatment of α7-related disorders, including dementias, pain-related ailments, depression, anxiety, and wound healing.

Original languageEnglish
Pages (from-to)4169-4180
Number of pages12
JournalBiochemistry
Volume49
Issue number19
DOIs
StatePublished - 18 May 2010
Externally publishedYes

Fingerprint

Nicotinic Receptors
Hydrogen
Hydrogen bonds
methyllycaconitine
(S)-(1-azabicyclo(2.2.2)oct-3-yl)carbamic acid (S)-1-(2-fluorophenyl) ethyl ester
Carbamates
Cholinergic Receptors
Static Electricity
Wound Healing
Dementia
Electrostatics
Anxiety
Depression
Pain

Cite this

@article{a676d2bd634340959660f733783d806d,
title = "Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human α7 nicotinic acetylcholine receptor",
abstract = "The interaction of the agonist JN403 with the human (h) α7 nicotinic acetylcholine receptor (AChR) was compared to that for the competitive antagonist methyllycaconitine (MLA). The receptor selectivity of JN403 was studied on the hα7, hα3β4, and hα4β2 AChRs. The results established that the cationic center and the hydrophobic group found in JN430 and MLA are important for the interaction with the AChRs. MLA preincubation inhibits JN403-induced Ca2+ influx in GH3-hα7 cells with a potency 160-fold higher than that when MLA is co-injected with JN403. The most probable explanation, based on our dynamics results, is that MLA (more specifically the 3-methyl-2,5-dioxopyrrole ring and the B-D rings) stabilizes the resting conformational state. The order of receptor specificity for JN403 is as follows: hα7 > hα3β4 (∼40-fold) > hα4β2 (∼500-fold). This specificity is based on a larger number of hydrogen bonds between the carbamate group (another pharmacophore) of JN403 and the hα7 sites, the electrostatic repulsion between the positively charged residues around the hα3β4 sites and the cationic center of JN403, fewer hydrogen bonds for the interaction of JN403 with the hα3β4 AChR, and an unfavorable van der Waals interaction between JN403 and the α4-β2 interface. The higher receptor specificity for JN403 could be important for the treatment of α7-related disorders, including dementias, pain-related ailments, depression, anxiety, and wound healing.",
author = "Arias, {Hugo R.} and Gu, {Ruo Xu} and Dominik Feuerbach and Wei, {Dong Qing}",
year = "2010",
month = "5",
day = "18",
doi = "10.1021/bi901999v",
language = "English",
volume = "49",
pages = "4169--4180",
journal = "Biochemistry",
issn = "0006-2960",
number = "19",

}

Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human α7 nicotinic acetylcholine receptor. / Arias, Hugo R.; Gu, Ruo Xu; Feuerbach, Dominik; Wei, Dong Qing.

In: Biochemistry, Vol. 49, No. 19, 18.05.2010, p. 4169-4180.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human α7 nicotinic acetylcholine receptor

AU - Arias, Hugo R.

AU - Gu, Ruo Xu

AU - Feuerbach, Dominik

AU - Wei, Dong Qing

PY - 2010/5/18

Y1 - 2010/5/18

N2 - The interaction of the agonist JN403 with the human (h) α7 nicotinic acetylcholine receptor (AChR) was compared to that for the competitive antagonist methyllycaconitine (MLA). The receptor selectivity of JN403 was studied on the hα7, hα3β4, and hα4β2 AChRs. The results established that the cationic center and the hydrophobic group found in JN430 and MLA are important for the interaction with the AChRs. MLA preincubation inhibits JN403-induced Ca2+ influx in GH3-hα7 cells with a potency 160-fold higher than that when MLA is co-injected with JN403. The most probable explanation, based on our dynamics results, is that MLA (more specifically the 3-methyl-2,5-dioxopyrrole ring and the B-D rings) stabilizes the resting conformational state. The order of receptor specificity for JN403 is as follows: hα7 > hα3β4 (∼40-fold) > hα4β2 (∼500-fold). This specificity is based on a larger number of hydrogen bonds between the carbamate group (another pharmacophore) of JN403 and the hα7 sites, the electrostatic repulsion between the positively charged residues around the hα3β4 sites and the cationic center of JN403, fewer hydrogen bonds for the interaction of JN403 with the hα3β4 AChR, and an unfavorable van der Waals interaction between JN403 and the α4-β2 interface. The higher receptor specificity for JN403 could be important for the treatment of α7-related disorders, including dementias, pain-related ailments, depression, anxiety, and wound healing.

AB - The interaction of the agonist JN403 with the human (h) α7 nicotinic acetylcholine receptor (AChR) was compared to that for the competitive antagonist methyllycaconitine (MLA). The receptor selectivity of JN403 was studied on the hα7, hα3β4, and hα4β2 AChRs. The results established that the cationic center and the hydrophobic group found in JN430 and MLA are important for the interaction with the AChRs. MLA preincubation inhibits JN403-induced Ca2+ influx in GH3-hα7 cells with a potency 160-fold higher than that when MLA is co-injected with JN403. The most probable explanation, based on our dynamics results, is that MLA (more specifically the 3-methyl-2,5-dioxopyrrole ring and the B-D rings) stabilizes the resting conformational state. The order of receptor specificity for JN403 is as follows: hα7 > hα3β4 (∼40-fold) > hα4β2 (∼500-fold). This specificity is based on a larger number of hydrogen bonds between the carbamate group (another pharmacophore) of JN403 and the hα7 sites, the electrostatic repulsion between the positively charged residues around the hα3β4 sites and the cationic center of JN403, fewer hydrogen bonds for the interaction of JN403 with the hα3β4 AChR, and an unfavorable van der Waals interaction between JN403 and the α4-β2 interface. The higher receptor specificity for JN403 could be important for the treatment of α7-related disorders, including dementias, pain-related ailments, depression, anxiety, and wound healing.

UR - http://www.scopus.com/inward/record.url?scp=77952386905&partnerID=8YFLogxK

U2 - 10.1021/bi901999v

DO - 10.1021/bi901999v

M3 - Article

C2 - 20377277

AN - SCOPUS:77952386905

VL - 49

SP - 4169

EP - 4180

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 19

ER -